These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24894324)

  • 21. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
    Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
    Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
    Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
    Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis.
    Wong WR; Tsai HJ; Hong HS
    Chang Gung Med J; 2003 Jul; 26(7):485-95. PubMed ID: 14515971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
    Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
    J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
    Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T;
    Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TOPICAL CORTICOSTEROIDS BUT NOT CALCINEURIN INHIBITORS INDUCED ATROPHY AFTER FOUR WEEKS.
    Jiráková A; Rob F; Sečníková Z; Koblová K; Džambová M; Rajská L; Göpfertová D; Pellacani G; Malý M; Lotti T; Hercogová J
    J Biol Regul Homeost Agents; 2015; 29(3):701-6. PubMed ID: 26403410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
    Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
    J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography.
    Aschoff R; Schmitt J; Knuschke P; Koch E; Bräutigam M; Meurer M
    Exp Dermatol; 2011 Oct; 20(10):832-6. PubMed ID: 21771098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
    J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
    Kirsner RS; Heffernan MP; Antaya R
    Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis.
    Danby SG; Chittock J; Brown K; Albenali LH; Cork MJ
    Br J Dermatol; 2014 Apr; 170(4):914-21. PubMed ID: 24328907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.